Alterations in basement membrane immunoreactivity of the diabetic retina in three diabetic mouse models

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 251, Issue 3, 2013, Pages 763-775

  Abari, E ^a   Kociok, N ^a   Hartmann, U ^b   Semkova, I ^a   Paulsson, M ^b   Lo, A ^c   Joussen, A M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Basement membranes; Diabetic retinopathy; Immunocytochemistry; Mouse models; Retina

Indexed keywords

COLLAGEN TYPE 4; ENTACTIN; GLUCOSE; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; LAMININ; LEPTIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASEMENT MEMBRANE; BRUCH MEMBRANE; CONTROLLED STUDY; DIABETIC RETINOPATHY; GLUCOSE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; MOUSE STRAIN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; STREPTOZOCIN DIABETES; WILD TYPE;

ANIMALS; BASEMENT MEMBRANE; BLOOD GLUCOSE; COLLAGEN TYPE IV; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DISEASE MODELS, ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; LAMININ; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, FLUORESCENCE;

EID: 84877127176     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-012-2237-8     Document Type: Article

References (50)

1. Cai J, Boulton M (2002) The pathogenesis of diabetic retinopathy: old concepts and new questions. Eye (Lond) 16:242-260
2. Archer DB (1998) External beam radiotherapy in the management of subfoveal choroidal neovascular membranes of the eye: a new treatment for an old disease. Ulst Med J 67(Suppl 1):41-46
3. Engerman RL, Kern TS (1995) Retinopathy in animal models of diabetes. Diabetes Metab Rev 11:109-120
4. Feit-Leichman RA, Kinouchi R, Takeda M, Fan Z, Mohr S, Kern TS, Chen DF (2005) Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes. Invest Ophthalmol Vis Sci 46:4281-4287
5. Roy S, Maiello M, Lorenzi M (1994) Increased expression of basement membrane collagen in human diabetic retinopathy. J Clin Invest 93:438-442
6. Roy S, Sato T, Paryani G, Kao R (2003) Downregulation of fibronectin overexpression reduces basement membrane thickening and vascular lesions in retinas of galactose-fed rats. Diabetes 52:1229-1234
7. Risteli J, Draeger KE, Regitz G, Neubauer HP (1982) Increase in circulating basement membrane antigens in diabetic rats and effects of insulin treatment. Diabetologia 23:266-269
8. Brocks DG, Neubauer HP, Strecker H (1985) Type IV collagen antigens in serum of diabetic rats: a marker for basement membrane collagen biosynthesis. Diabetologia 28:928-932
9. Paulsson M, Timpl R, Brocks DG, Neubauer H (1988) Increased basement membrane heparan sulphate proteoglycan in serum of diabetic rats. Scand J Clin Lab Invest 48:379-380, Letter to Editor article
10. Kern JS, Loeckermann S, Fritsch A, Hausser I, Roth W, Magin TM, Mack C, Muller ML, Paul O, Ruther P, Bruckner-Tuderman L (2009) Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity. Mol Ther 17:1605-1615
11. Mayer U, Mann K, Timpl R, Murphy G (1993) Sites of nidogen cleavage by proteases involved in tissue homeostasis and remodelling. Eur J Biochem 217:877-884
12. Nishikawa T, Giardino I, Edelstein D, Brownlee M (2000) Changes in diabetic retinal matrix protein mRNA levels in a common transgenic mouse strain. Curr Eye Res 21:581-587
13. Libby RT, Champliaud MF, Claudepierre T, Xu Y, Gibbons EP, Koch M, Burgeson RE, Hunter DD, Brunken WJ (2000) Laminin expression in adult and developing retinae: evidence of two novel CNS laminins. J Neurosci 20:6517-6528
14. Lin WL, Essner E, McCarthy KJ, Couchman JR (1992) Ultrastructural immunocytochemical localization of chondroitin sulfate proteoglycan in Bruch's membrane of the rat. Invest Ophthalmol Vis Sci 33:2072-2075
15. Marshall GE, Konstas AG, Reid GG, Edwards JG, Lee WR (1992) Type IV collagen and laminin in Bruch's membrane and basal linear deposit in the human macula. Br J Ophthalmol 76:607-614
16. Grierson I, Hiscott P, Hogg P, Robey H, Mazure A, Larkin G (1994) Development, repair and regeneration of the retinal pigment epithelium. Eye 8(Pt 2):255-262
17. Libby RT, Brunken WJ, Hunter DD (2000) Roles of the extracellular matrix in retinal development and maintenance. Results Probl Cell Differ 31:115-140
18. Bystrom B, Virtanen I, Rousselle P, Gullberg D, Pedrosa-Domellof F (2006) Distribution of laminins in the developing human eye. Invest Ophthalmol Vis Sci 47:777-785
19. Duran-Jimenez B, Dobler D, Moffatt S, Rabbani N, Streuli CH, Thornalley PJ, Tomlinson DR, Gardiner NJ (2009) Advanced glycation end products in extracellular matrix proteins contribute to the failure of sensory nerve regeneration in diabetes. Diabetes 58:2893-2903
20. Sado Y, Kagawa M, Naito I, Ueki Y, Seki T, Momota R, Oohashi T, Ninomiya Y (1998) Organization and expression of basement membrane collagen IV genes and their roles in human disorders. J Biochem 123:767-776
21. Chen L, Miyamura N, Ninomiya Y, Handa JT (2003) Distribution of the collagen IV isoforms in human Bruch's membrane. Br J Ophthalmol 87:212-215
22. Fox JW, Mayer U, Nischt R, Aumailley M, Reinhardt D, Wiedemann H, Mann K, Timpl R, Krieg T, Engel J et al (1991) Recombinant nidogen consists of three globular domains and mediates binding of laminin to collagen type IV. EMBO J 10:3137-3146
23. Kimura N, Toyoshima T, Kojima T, Shimane M (1998) Entactin-2: a new member of basement membrane protein with high homology to entactin/nidogen. Exp Cell Res 241:36-45
24. Miosge N, Holzhausen S, Zelent C, Sprysch P, Herken R (2001) Nidogen-1 and nidogen-2 are found in basement membranes during human embryonic development. Histochem J 33:523-530
25. Aumailley M, Battaglia C, Mayer U, Reinhardt D, Nischt R, Timpl R, Fox JW (1993) Nidogen mediates the formation of ternary complexes of basement membrane components. Kidney Int 43:7-12
26. Kohfeldt E, Sasaki T, Gohring W, Timpl R (1998) Nidogen-2: a new basement membrane protein with diverse binding properties. J Mol Biol 282:99-109
27. Murshed M, Smyth N, Miosge N, Karolat J, Krieg T, Paulsson M, Nischt R (2000) The absence of nidogen 1 does not affect murine basement membrane formation. Mol Cell Biol 20:7007-7012
28. Schymeinsky J, Nedbal S, Miosge N, Poschl E, Rao C, Beier DR, Skarnes WC, Timpl R, Bader BL (2002) Gene structure and functional analysis of the mouse nidogen-2 gene: nidogen-2 is not essential for basement membrane formation in mice. Mol Cell Biol 22:6820-6830
29. Bader BL, Smyth N, Nedbal S, Miosge N, Baranowsky A, Mokkapati S, Murshed M, Nischt R (2005) Compound genetic ablation of nidogen 1 and 2 causes basement membrane defects and perinatal lethality in mice. Mol Cell Biol 25:6846-6856
30. Kunze A, Abari E, Semkova I, Paulsson M, Hartmann U (2010) Deposition of nidogens and other basement membrane proteins in the young and aging mouse retina. Ophthalmic Res 43:108-112
31. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW (1998) Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 102:783-791
32. Villarroel M, Ciudin A, Hernandez C, Simo R (2010) Neurodegeneration: An early event of diabetic retinopathy. World J Diabetes 1:57-64
33. King AJ (2012) The use of animal models in diabetes research. Br J Pharmacol 166:877-894
34. Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, Lakey ND, Culpepper J, Moore KJ, Breitbart RE, Duyk GM, Tepper RI, Morgenstern JP (1996) Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84:491-495
35. Bruning JC, Winnay J, Bonner-Weir S, Taylor SI, Accili D, Kahn CR (1997) Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell 88:561-572
36. McEvoy RC, Andersson J, Sandler S, Hellerstrom C (1984) Multiple low-dose streptozotocin-induced diabetes in the mouse. Evidence for stimulation of a cytotoxic cellular immune response against an insulin-producing beta cell line. J Clin Invest 74:715-722
37. Stitt AW, Anderson HR, Gardiner TA, Archer DB (1994) Diabetic retinopathy: quantitative variation in capillary basement membrane thickening in arterial or venous environments. Br J Ophthalmol 78:133-137
38. Bai X, Dilworth DJ, Weng YC, Gould DB (2009) Developmental distribution of collagen IV isoforms and relevance to ocular diseases. Matrix Biol 28:194-201
39. Smyth N, Vatansever HS, Murray P, Meyer M, Frie C, Paulsson M, Edgar D (1999) Absence of basement membranes after targeting the LAMC1 gene results in embryonic lethality due to failure of endoderm differentiation. J Cell Biol 144:151-160
40. Willem M, Miosge N, Halfter W, Smyth N, Jannetti I, Burghart E, Timpl R, Mayer U (2002) Specific ablation of the nidogen-binding site in the laminin gamma1 chain interferes with kidney and lung development. Development 129:2711-2722
41. Costell M, Carmona R, Gustafsson E, Gonzalez-Iriarte M, Fassler R, Munoz-Chapuli R (2002) Hyperplastic conotruncal endocardial cushions and transposition of great arteries in perlecan-null mice. Circ Res 91:158-164
42. Poschl E, Schlotzer-Schrehardt U, Brachvogel B, Saito K, Ninomiya Y, Mayer U (2004) Collagen IV is essential for basement membrane stability but dispensable for initiation of its assembly during early development. Development 131:1619-1628
43. Pinzon-Duarte G, Daly G, Li YN, Koch M, Brunken WJ (2010) Defective formation of the inner limiting membrane in laminin beta2- and gamma3-null mice produces retinal dysplasia. Invest Ophthalmol Vis Sci 51:1773-1782
44. Hiscott P, Sheridan C, Magee RM, Grierson I (1999) Matrix and the retinal pigment epithelium in proliferative retinal disease. Prog Retin Eye Res 18:167-190
45. de Gooyer TE, Stevenson KA, Humphries P, Simpson DA, Gardiner TA, Stitt AW (2006) Retinopathy is reduced during experimental diabetes in a mouse model of outer retinal degeneration. Invest Ophthalmol Vis Sci 47:5561-5568
46. Stitt A, Gardiner TA, Alderson NL, Canning P, Frizzell N, Duffy N, Boyle C, Januszewski AS, Chachich M, Baynes JW, Thorpe SR (2002) The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes 51:2826-2832
47. Oshitari T, Polewski P, Chadda M, Li AF, Sato T, Roy S (2006) Effect of combined antisense oligonucleotides against high-glucose- and diabetes-induced overexpression of extracellular matrix components and increased vascular permeability. Diabetes 55:86-92
48. Halfter W, Willem M, Mayer U (2005) Basement membrane-dependent survival of retinal ganglion cells. Invest Ophthalmol Vis Sci 46:1000-1009
49. Bai Y, Xu J, Brahimi F, Zhuo Y, Sarunic MV, Saragovi HU (2010) An agonistic TrkB mAb causes sustained TrkB activation, delays RGC death, and protects the retinal structure in optic nerve axotomy and in glaucoma. Invest Ophthalmol Vis Sci 51:4722-4731
50. Martin PM, Roon P, Van Ells TK, Ganapathy V, Smith SB (2004) Death of retinal neurons in streptozotocin-induced diabetic mice. Invest Ophthalmol Vis Sci 45:3330-3336